SCHEMBL2857271

SCHEMBL2857271

COC(=O)c1ccc2[nH]nc(-c3ccnc4ccccc34)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 6/20 0.46
KDM4E B2RXH2 1/20 0.46
STAT3 P40763 1/20 0.46
HIF1A Q16665 1/20 0.46
FLT3 P36888 2/20 0.46
HDAC6 Q9UBN7 1/20 0.44
KIF11 P52732 1/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44
MAP2K4 P45985 2/20 0.44
GPR84 Q9NQS5 1/20 0.44
MAPK3 P27361 3/20 0.43
PARP1 P09874 1/20 0.42
DYRK1A Q13627 1/20 0.41
FGFR1 P11362 1/20 0.41
FLT1 P17948 1/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
MDH2 P40926 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864569 0.86 MAP2K4 (0.52) MAPK1FLT3HDAC6MAP2K4MAPK3
SCHEMBL2858312 0.80 LRRK2 (0.52) MAPK1KDM4ESTAT3HIF1AFLT3
SCHEMBL2857478 0.80 MAP2K4 (0.52) MAPK1KDM4ESTAT3HIF1AFLT3
SCHEMBL2863569 0.79 LRRK2 (0.56) MAPK1KDM4ESTAT3HIF1AFLT3
SCHEMBL2860104 0.79 PIM1 (0.53) MAPK1KDM4ESTAT3HIF1AFLT3
SCHEMBL5379661 0.79 MAPK1 (0.46) MAPK1KDM4ESTAT3HIF1AFLT3
SCHEMBL4903778 0.78 MAP2K4 (0.51) MAPK1KDM4EMAP2K4
SCHEMBL16502626 0.78 ALOX15 (0.53) MAPK1KDM4EHDAC6KIF11ALOX15
SCHEMBL2866668 0.77 ALOX15 (0.44) MAPK1KDM4ESTAT3HIF1AFLT3
Ethyl Acetate SCHEMBL27669812 0.76 PTGDR2 (0.45) MAPK1KDM4EMAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK1 1/4885KDM4E 2531/4885STAT3 224/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAPK1 1/4885KDM4E 2430/4885STAT3 103/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK1 1/4885KDM4E 2531/4885STAT3 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.